Gabelli Funds’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-540,240
Closed -$52.4M 1165
2019
Q3
$52.4M Sell
540,240
-82,227
-13% -$8.23M 0.35% 68
2019
Q2
$63.7M Buy
622,467
+30,329
+5% +$3.27M 0.41% 59
2019
Q1
$67.4M Buy
+592,138
New +$43.5M 0.42% 48

Gabelli Funds's ONCE Position: Q4 2019 in Review

Gabelli Funds sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 540,240 shares — an estimated $52.4M sold.

Gabelli Funds first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $67.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Gabelli Funds reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Gabelli Funds sold 540,240 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $52.4M.
  • Gabelli Funds first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Gabelli Funds's Spark Therapeutics, Inc. Common Stock position peaked at $67.4M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.